… Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of
sirolimuseluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY …

… with ST-elevation myocardial infarction8 and diabetics.9 The polymer-free stent platform
consists of a premounted, thin strut (50/60 µm) cobalt–chromium stent whose abluminal surface …

… incidence of death or myocardial infarction at 3 years tended to … the potentially associated
long-term risk of stent thrombosis. … of a sirolimus-eluting stent with a standard stent for coronary …

… the composite rate of target vessel myocardial infarction (TV-MI), cardiac death or
ischemia-… - and sirolimus-eluting stents in small coronary vessels. Eur Heart J. 2006 Feb;27(3):260–6. …

… of safety (cardiac death or target vessel-related myocardial infarction) and efficacy (target …
-eluting or sirolimus-eluting stents, compared with durable polymer zotarolimus-eluting stents, …

… Major clinical exclusion criteria were ST-segment elevation myocardial infarction within
the past 72 h; chronic renal insufficiency with serum creatinine levels >2.0 mg/dl; known …

… Implantation of early-generation metallic drug-eluting stents (DES) in patients with acute
myocardial infarction (AMI) is associated with poor vessel wall healing. Use of biodegradable …

… late hazards (namely stent thrombosis, target vessel myocardial infarction, or restenosis). …
vitamin K agents, ST-elevation myocardial infarction secondary to stent thrombosis, and known …

… Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial
infarction: the REVELATION randomized trial". J Am Coll Cardiol Intv 2019;12:17: 1691-1699. …

… -vessel failure at 1 year, using a sirolimus-eluting stent, compared with uncoated stents.
Rates of stent thrombosis were similar in the coated and uncoated stent groups in both studies. …